Quent Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.63M Sell
5,033
-509
-9% -$516K 0.33% 49
2025
Q4
$5.96M Buy
5,542
+144
+3% +$138K 0.43% 43
2025
Q3
$4.12M Sell
5,398
-151
-3% -$112K 0.35% 52
2025
Q2
$4.33M Sell
5,549
-26
-0.5% -$20.2K 0.42% 49
2025
Q1
$4.6M Buy
5,575
+136
+3% +$113K 0.48% 42
2024
Q4
$4.2M Buy
5,439
+288
+6% +$238K 0.43% 43
2024
Q3
$4.56M Buy
5,151
+24
+0.5% +$21.6K 0.46% 41
2024
Q2
$4.64M Buy
5,127
+184
+4% +$147K 0.51% 39
2024
Q1
$3.85M Buy
4,943
+249
+5% +$177K 0.45% 42
2023
Q4
$2.74M Buy
4,694
+345
+8% +$201K 0.37% 47
2023
Q3
$2.34M Sell
4,349
-74
-2% -$38.1K 0.36% 50
2023
Q2
$2.07M Buy
4,423
+48
+1% +$20.1K 0.32% 50
2023
Q1
$1.5M Buy
4,375
+171
+4% +$57.7K 0.26% 57
2022
Q4
$1.54M Buy
4,204
+305
+8% +$108K 0.28% 50
2022
Q3
$1.26M Buy
3,899
+192
+5% +$60.8K 0.26% 54
2022
Q2
$1.2M Sell
3,707
-2,035
-35% -$611K 0.26% 55
2022
Q1
$1.64M Sell
5,742
-1,206
-17% -$310K 0.3% 51
2021
Q4
$1.92M Buy
+6,948
New +$1.76M 0.41% 49

Other funds holding LLY

Quent Capital's LLY Position: Q1 2026 in Review

Quent Capital reduced its Eli Lilly (LLY) stake by 9.2% in Q1 2026, selling an estimated $516K and leaving 5,033 shares worth $4.63M. The position accounts for 0.33% of the portfolio, ranked #49.

Quent Capital first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $5.96M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Quent Capital held 5,033 shares of Eli Lilly worth $4.63M as of Q1 2026.
  • Quent Capital sold 509 Eli Lilly shares in Q1 2026, an estimated $516K.
  • Eli Lilly made up 0.33% of Quent Capital's portfolio in Q1 2026, its #49 holding.
  • Quent Capital first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • Quent Capital's Eli Lilly position peaked at $5.96M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.